商品簡介
This portrait of the global debate over patent law and access to essential medicines focuses on public health concerns about HIV/AIDS, malaria, tuberculosis, the SARS virus, influenza, and diseases of poverty. The essays explore the diplomatic negotiations and disputes in key international fora, such as the World Trade Organization, the World Health Organization and the World Intellectual Property Organization. Drawing upon international trade law, innovation policy, intellectual property law, health law, human rights and philosophy, the authors seek to canvass policy solutions which encourage and reward worthwhile pharmaceutical innovation while ensuring affordable access to advanced medicines. A number of creative policy options are critically assessed, including the development of a Health Impact Fund, prizes for medical innovation, the use of patent pools, open-source drug development and forms of 'creative capitalism'.
作者簡介
Thomas Pogge is Leitner Professor of Philosophy and International Affairs at Yale University, Professorial Fellow at the ANU Centre for Applied Philosophy and Public Ethics (CAPPE), Research Director at the Oslo University Centre for the Study of Mind in Nature (CSMN), and Adjunct Professor at the University of Central Lancashire.
Matthew Rimmer is a Senior Lecturer and Associate Director of research at the ANU College of Law, Australian National University, and an Associate Director of the Australian Centre for Intellectual Property in Agriculture.
Kim Rubenstein is Professor and Director of the Centre for International and Public Law (CIPL) in the ANU College of Law, Australian National University.
